A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

US Defense Dept Invests in Australian Rapid COVID-19 Test


The United States Department of Defense has entered into a $231 million agreement with the Australian company, Ellume, to fund the manufacture of its rapid and inexpensive COVID-19 test. Available without a prescription, the COVID-19 test uses a sample gathered with a short nasal swab that is then placed into a digital analyzer connected to a smartphone app. Results are available within 15 minutes and the cost per test is approximately $30. In December, the US Food and Drug Administration granted the Ellume test an Emergency Use Authorization after it showed 96% effectiveness in test subjects ages 2 and older. The investment will enable Ellume to build a US-based manufacturing plant that will make more than 500,000 tests per day. The agreement guarantees that the US will receive 8.5 million tests. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy